Since tumor-derived ROS also upregulate TAM PD-L1 expression [227], these results suggest that elevated ROS levels exhibit complex crosstalk with PD-1/PD-L-mediated immunosuppression in TME, escaping tumor cells from immune attack. The gene discussed is CD274; the disease is neoplasm.